These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 38303892)
1. Human antigen R knockdown attenuates the invasive activity of oral cancer cells through inactivation of matrix metalloproteinase-1 gene expression. Kakuguchi W; Kitamura T; Takahashi T; Yanagawa-Matsuda A; Fang CY; Ohiro Y; Higashino F J Dent Sci; 2024 Jan; 19(1):154-161. PubMed ID: 38303892 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517 [TBL] [Abstract][Full Text] [Related]
3. HuR knockdown changes the oncogenic potential of oral cancer cells. Kakuguchi W; Kitamura T; Kuroshima T; Ishikawa M; Kitagawa Y; Totsuka Y; Shindoh M; Higashino F Mol Cancer Res; 2010 Apr; 8(4):520-8. PubMed ID: 20332213 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Akool el-S; Kleinert H; Hamada FM; Abdelwahab MH; Förstermann U; Pfeilschifter J; Eberhardt W Mol Cell Biol; 2003 Jul; 23(14):4901-16. PubMed ID: 12832476 [TBL] [Abstract][Full Text] [Related]
5. ATP potentiates interleukin-1 beta-induced MMP-9 expression in mesangial cells via recruitment of the ELAV protein HuR. Huwiler A; Akool el-S; Aschrafi A; Hamada FM; Pfeilschifter J; Eberhardt W J Biol Chem; 2003 Dec; 278(51):51758-69. PubMed ID: 14523003 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression at invasive front of squamous cell and verrucous carcinoma in oral cavity. Mohtasham N; Babakoohi S; Shiva A; Shadman A; Kamyab-Hesari K; Shakeri MT; Sharifi-Sistani N Pathol Res Pract; 2013 Feb; 209(2):110-4. PubMed ID: 23273944 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of HuR Inhibits the Progression of Esophageal Cancer through Interleukin-18. Xu X; Song C; Chen Z; Yu C; Wang Y; Tang Y; Luo J Cancer Res Treat; 2018 Jan; 50(1):71-87. PubMed ID: 28231690 [TBL] [Abstract][Full Text] [Related]
8. A novel cantharidin analog N-benzylcantharidinamide reduces the expression of MMP-9 and invasive potentials of Hep3B via inhibiting cytosolic translocation of HuR. Lee JY; Chung TW; Choi HJ; Lee CH; Eun JS; Han YT; Choi JY; Kim SY; Han CW; Jeong HS; Ha KT Biochem Biophys Res Commun; 2014 May; 447(2):371-7. PubMed ID: 24735540 [TBL] [Abstract][Full Text] [Related]
9. Kalopanaxsaponin A inhibits the invasion of human oral squamous cell carcinoma by reducing metalloproteinase-9 mRNA stability and protein trafficking. Hwang YS; Park KK; Chung WY Biol Pharm Bull; 2012; 35(3):289-300. PubMed ID: 22382313 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9. Yuan Z; Sanders AJ; Ye L; Wang Y; Jiang WG Oncol Rep; 2011 Jul; 26(1):237-45. PubMed ID: 21503589 [TBL] [Abstract][Full Text] [Related]
11. Expression of HuR is associated with increased cyclooxygenase-2 expression in uterine cervical carcinoma. Lim SJ; Kim HJ; Kim JY; Park K; Lee CM Int J Gynecol Pathol; 2007 Jul; 26(3):229-34. PubMed ID: 17581403 [TBL] [Abstract][Full Text] [Related]
12. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. Al-Ahmadi W; Al-Ghamdi M; Al-Souhibani N; Khabar KS J Pathol; 2013 May; 230(1):28-38. PubMed ID: 23401122 [TBL] [Abstract][Full Text] [Related]
13. Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell. Jia ZC; Wan YL; Tang JQ; Dai Y; Liu YC; Wang X; Zhu J Int J Colorectal Dis; 2012 Apr; 27(4):437-45. PubMed ID: 22076613 [TBL] [Abstract][Full Text] [Related]
14. Saturated fatty acids induce post-transcriptional regulation of HAMP mRNA via AU-rich element-binding protein, human antigen R (HuR). Lu S; Mott JL; Harrison-Findik DD J Biol Chem; 2015 Oct; 290(40):24178-89. PubMed ID: 26304124 [TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion. Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466 [TBL] [Abstract][Full Text] [Related]
16. Caspase-mediated cleavage of RNA-binding protein HuR regulates c-Myc protein expression after hypoxic stress. Talwar S; Jin J; Carroll B; Liu A; Gillespie MB; Palanisamy V J Biol Chem; 2011 Sep; 286(37):32333-43. PubMed ID: 21795698 [TBL] [Abstract][Full Text] [Related]
17. A Feed-Forward Regulatory Loop between HuR and the Long Noncoding RNA HOTAIR Promotes Head and Neck Squamous Cell Carcinoma Progression and Metastasis. Xu CZ; Jiang C; Wu Q; Liu L; Yan X; Shi R Cell Physiol Biochem; 2016; 40(5):1039-1051. PubMed ID: 27941336 [TBL] [Abstract][Full Text] [Related]
18. The MK2/HuR signaling pathway regulates TNF-α-induced ICAM-1 expression by promoting the stabilization of ICAM-1 mRNA. Wu T; Shi JX; Geng S; Zhou W; Shi Y; Su X BMC Pulm Med; 2016 May; 16(1):84. PubMed ID: 27215284 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Denkert C; Weichert W; Pest S; Koch I; Licht D; Köbel M; Reles A; Sehouli J; Dietel M; Hauptmann S Cancer Res; 2004 Jan; 64(1):189-95. PubMed ID: 14729623 [TBL] [Abstract][Full Text] [Related]
20. Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells. Kakuguchi W; Nomura T; Kitamura T; Otsuguro S; Matsushita K; Sakaitani M; Maenaka K; Tei K Cancer Med; 2018 Dec; 7(12):6269-6280. PubMed ID: 30449075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]